Aspen Pharmacare shares lifted 4% on Monday, after the company announced it had received approval for its generic injectable semaglutide in Canada.
Related Posts
News24 | Four people, including well-known media personality, arrested in Russian mercenary case
- CoreNews Africa
- November 29, 2025
- 0
Three men, who were allegedly heading to Russia to serve as mercenaries in the Russian Federation Military, were arrested at OR Tambo International Airport on […]
News24 | amaBhungane | SA’s gambling crisis: facilitators, criminals and money launderers
- CoreNews Africa
- December 11, 2025
- 0
Greedy local financial service giants and offshore betting pirates are helping drive our vast and fast-growing online gambling crisis, while the industry is also shaping […]
News24 | Sports bodies hit out at funding delays amid McKenzie’s R31m spend row
- CoreNews Africa
- July 25, 2026
- 0
Delayed and limited government funding is forcing SA athletes and parents to pay their own way to international competitions, while the women’s softball team has […]